These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 34549691)

  • 1. Erythrocyte membranes beta-adrenoreactivity changes after renal denervation in patients with resistant hypertension, relationship with antihypertensive and cardioprotective intervention efficacy.
    Zyubanova IV; Falkovskaya AY; Mordovin VF; Manukyan MA; Pekarskij SE; Lichikaki VA; Shalishev IG; Rebrova TY; Muslimova EF; Afanasiev SA
    Kardiologiia; 2021 Aug; 61(8):32-39. PubMed ID: 34549691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibility of evaluating the effectiveness of renal artery sympathetic denervation in resistant hypertension early after radiofrequency ablation].
    Rebrova TY; Ripp TM; Afanasiev SA; Mordovin VF; Muslimova EF
    Ter Arkh; 2016; 88(8):10-13. PubMed ID: 27636920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory and Resistant Hypertension in Patients with Type 2 Diabetes Mellitus: Different Response to Renal Denervation.
    Falkovskaya AY; Mordovin VF; Pekarskiy SE; Manukyan MA; Ripp TM; Zyubanova IV; Lichikaki VA; Sitkova ES; Gusakova AM; Baev AE
    Kardiologiia; 2021 Mar; 61(2):54-61. PubMed ID: 33734049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic approaches to the Rational Use of trip-le combination therapy with a fixed combination of amlodipine, indapamide and perindopril arginine (TRIPLE COMBINATION) in patients with hypertension who do not control blood pressure on conventional treatment. (Description and main results of the TRIO program)].
    Mareev VY; Minina YV; Begrambekova YL; Levin AM
    Kardiologiia; 2020 Jun; 60(5):1149. PubMed ID: 32515706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
    Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G
    J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Criteria for selecting patients with resistant hypertension for a renal sympathetic denervation].
    Ripp TM; Rebrova TY; Mordovin VF; Afanasiev SA; Pekarsky SE; Semke GV; Falkovskaya AY; Lichikaki VA; Tsymbalyuk EV
    Ter Arkh; 2016; 88(8):14-18. PubMed ID: 27636921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension.
    Ezzahti M; Moelker A; Friesema EC; van der Linde NA; Krestin GP; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):135-41. PubMed ID: 24131897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative Efficacy of the Influence of Fixed Combinations of Antihypertensive Drugs That Block the Renin-Angiotensin-Aldosterone System, With Thiazide Diuretics on the Parameters of Ambulatory Blood Pressure Monitoring].
    Ostroumova OD; Garelik IA
    Kardiologiia; 2016 Dec; 56(12):20-26. PubMed ID: 28290800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
    Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the spatial QRS-T angle for assessing the severity of heart damage in patients with arterial hypertension.
    Sakhnova TA; Blinova EV; Saidova MA
    Kardiologiia; 2021 Nov; 61(11):49-56. PubMed ID: 34882078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to renal denervation for resistant arterial hypertension: a single center experience.
    Rohla M; Nahler A; Lambert T; Reiter C; Gammer V; Grund M; Blessberger H; Kammler J; Kypta A; Saleh K; Huber K; Steinwender C; Weiss TW
    J Hypertens; 2016 Jan; 34(1):123-9. PubMed ID: 26556567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.